uniQure (QURE) Retained Earnings (2015 - 2026)
uniQure (QURE) recorded quarterly Retained Earnings of -$1.4 billion in Q1 2026, down 2274.48% quarter-over-quarter from -$58.2 million in Q4 2025, and down 2469.41% on a YoY basis from $58.3 million in Q1 2025.
uniQure (QURE) Retained Earnings (2015 - 2026) Analysis & Trends
uniQure's Retained Earnings history runs 12 years deep, the most recent figure standing at -$1.4 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 2469.41% year-over-year to -$1.4 billion; the TTM figure through Mar 2026 stood at -$1.4 billion (down 2469.41% YoY), while the FY2025 annual figure was -$58.2 million, up 94.85% from the prior year.
- Retained Earnings was -$1.4 billion for Q1 2026 at uniQure, down from -$58.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$39.3 million in Q1 2022 to a low of -$1.4 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$508.6 million across 5 years, with a median of -$67.6 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Retained Earnings jumped 95.24% in 2022, then slumped 2469.41% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$58.3 million in 2022, then gained by 8.06% to -$53.6 million in 2023, then slumped by 2008.14% to -$1.1 billion in 2024, then soared by 94.85% to -$58.2 million in 2025, then slumped by 2274.48% to -$1.4 billion in 2026.
- The last three Retained Earnings figures came in at -$1.4 billion (Q1 2026), -$58.2 million (Q4 2025), and -$1.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | -1.38 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.38 Bn |
| Dec 31, 2025 | -58.22 Mn |
| Sep 30, 2025 | -1.29 Bn |
| Jun 30, 2025 | -58.90 Mn |
| Mar 31, 2025 | -53.81 Mn |
| Dec 31, 2024 | -1.13 Bn |
| Sep 30, 2024 | -1.06 Bn |
| Jun 30, 2024 | -1.01 Bn |
| Mar 31, 2024 | -956.03 Mn |
| Dec 31, 2023 | -53.60 Mn |
| Sep 30, 2023 | -58.56 Mn |
| Jun 30, 2023 | -727.63 Mn |
| Mar 31, 2023 | -52.49 Mn |
| Dec 31, 2022 | -58.30 Mn |
| Sep 30, 2022 | -588.74 Mn |
| Jun 30, 2022 | -67.63 Mn |
| Mar 31, 2022 | -39.31 Mn |
| Dec 31, 2021 | -28.90 Mn |
| Sep 30, 2021 | -463.35 Mn |
| Jun 30, 2021 | -426.82 Mn |